PMC:7205724 / 172-374
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 80-87 | Species | denotes | patient | Tax:9606 |
5 | 159-167 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 159-167 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T3 | 49-64 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T4 | 112-127 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 49-64 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T3 | 112-127 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T2 | 159-167 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 9-97 | Sentence | denotes | • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |
T6 | 98-168 | Sentence | denotes | • The use of corticosteroids might accelerate recovery from COVID-19. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
3 | 80-87 | Species | denotes | patient | Tax:9606 |
5 | 159-167 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T24 | 9-10 | IN | denotes | • |
T25 | 12-16 | NNP | denotes | IVIG |
T26 | 16-17 | -COMMA- | denotes | , |
T27 | 18-26 | VBN | denotes | combined |
T28 | 27-31 | IN | denotes | with |
T29 | 32-45 | NN | denotes | moderate-dose |
T30 | 46-48 | IN | denotes | of |
T31 | 49-64 | NNS | denotes | corticosteroids |
T32 | 64-65 | -COMMA- | denotes | , |
T33 | 66-71 | MD | denotes | might |
T34 | 72-79 | VB | denotes | improve |
T35 | 80-87 | NN | denotes | patient |
T36 | 88-96 | NNS | denotes | outcomes |
T37 | 98-99 | PDT | denotes | • |
T38 | 101-104 | DT | denotes | The |
T39 | 105-108 | NN | denotes | use |
T40 | 109-111 | IN | denotes | of |
T41 | 112-127 | NNS | denotes | corticosteroids |
T42 | 128-133 | MD | denotes | might |
T43 | 134-144 | VB | denotes | accelerate |
T44 | 145-153 | NN | denotes | recovery |
T45 | 154-158 | IN | denotes | from |
T46 | 159-167 | NN | denotes | COVID-19 |
T47 | 169-170 | PDT | denotes | • |
T48 | 172-174 | DT | denotes | No |
T49 | 175-185 | VBN | denotes | controlled |
T50 | 186-194 | JJ | denotes | clinical |
T51 | 195-201 | NNS | denotes | trials |
R20 | T25 | T24 | arg1Of | IVIG,• |
R21 | T25 | T26 | arg1Of | IVIG,"," |
R22 | T25 | T27 | arg2Of | IVIG,combined |
R23 | T27 | T28 | arg1Of | combined,with |
R24 | T29 | T28 | arg2Of | moderate-dose,with |
R25 | T29 | T30 | arg1Of | moderate-dose,of |
R26 | T31 | T30 | arg2Of | corticosteroids,of |
R27 | T34 | T32 | arg1Of | improve,"," |
R28 | T25 | T33 | arg1Of | IVIG,might |
R29 | T34 | T33 | arg2Of | improve,might |
R30 | T25 | T34 | arg1Of | IVIG,improve |
R31 | T36 | T34 | arg2Of | outcomes,improve |
R32 | T36 | T35 | arg1Of | outcomes,patient |
R33 | T39 | T37 | arg1Of | use,• |
R34 | T39 | T38 | arg1Of | use,The |
R35 | T39 | T40 | arg1Of | use,of |
R36 | T41 | T40 | arg2Of | corticosteroids,of |
R37 | T39 | T42 | arg1Of | use,might |
R38 | T43 | T42 | arg2Of | accelerate,might |
R39 | T39 | T43 | arg1Of | use,accelerate |
R40 | T44 | T43 | arg2Of | recovery,accelerate |
R41 | T44 | T45 | arg1Of | recovery,from |
R42 | T46 | T45 | arg2Of | COVID-19,from |
R43 | T51 | T47 | arg1Of | trials,• |
R44 | T51 | T48 | arg1Of | trials,No |
R45 | T51 | T49 | arg2Of | trials,controlled |
R46 | T51 | T50 | arg1Of | trials,clinical |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 159-167 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 9-97 | Sentence | denotes | • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |
T6 | 98-168 | Sentence | denotes | • The use of corticosteroids might accelerate recovery from COVID-19. |